Corcept Therapeutics | CORT - صافي الدخل





صافي الدخل تغيير تاريخ
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Alaunos Therapeutics USD -1.01M 153K 2026-03
ANI Pharmaceuticals USD 24.71M 4.78M 2026-06
Ardelyx USD -37.6M 37.2M 2026-03
Aurora Cannabis CAD -71.1M 72.92M 2026-03
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Canopy Growth CAD -157.11M 94.49M 2026-03
Corcept Therapeutics USD 42.14M 73.9M 2026-06
Eli Lilly USD 7.1B 301M 2026-06
J&J USD 5.53B 299M 2026-06
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Merck USD -1.34B 2.9B 2026-06
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Novartis USD 3.26B 108M 2026-06
Novartis USD 3.16B 747M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 4.65M 1.74M 2026-06
Pfizer USD -248M 2.94B 2026-06
Supernus Pharmaceuticals USD -58.37M 56.08M 2026-06
TG Therapeutics USD 7.78M 12M 2026-06